|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/574 | (2006.01) |
| G01N2333/723 | (2013.01) | ||
| G01N 33/57434 | (2013.01) |
| (11) | Patento numeris | 3353553 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16849728.7 |
| Europos patento paraiškos padavimo data | 2016-09-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-08-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-11-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/053387 |
| Data | 2016-09-23 |
| (87) | Numeris | WO 2017/053763 |
| Data | 2017-03-30 |
| (30) | Numeris | Data | Šalis |
| 201562233206 P | 2015-09-25 | US |
| (72) |
DITTAMORE, Ryan , US
|
| (73) |
Epic Sciences, Inc. ,
9381 Judicial Drive, Suite 200, San Diego, CA 92121,
US
|
| (54) | ANDROGEN RECEPTOR VARIANT 7 AS A BIOMARKER FOR TREATMENT SELECTION IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) |
| ANDROGEN RECEPTOR VARIANT 7 AS A BIOMARKER FOR TREATMENT SELECTION IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) |